START Dallas
Fort Worth, Texas 76104
4 studies enrolling now · 4 studies all time
What they study most
Advanced Malignancies, Cancer, G12D Mutated KRAS, Gastric Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Hepatic Cancer, High Grade Neuroendocrine Cancer, Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Prostate Cancer, Renal Carcinoma (Clear and Non-clear Cell)
Studies at this site
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer — Recruiting now
- Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies — Recruiting now
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors — Recruiting now
- TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers — Recruiting now